Brent Warner
Net worth: 859 032 $ as of 30/04/2024
Profile
Brent Warner served as Vice President-Gene Therapy & Rare Disease at Novartis Pharmaceuticals Canada, Inc. from 2019 to 2022.
He then became President-Gene Therapy at Poseida Therapeutics, Inc. from 2022 to 2024.
Mr. Warner obtained an undergraduate degree and an MBA from Northwood University (Michigan).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/03/2024 | 419,040 ( 0.43% ) | 859 032 $ | 30/04/2024 |
Former positions of Brent Warner
| Companies | Position | End |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2024 |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Corporate Officer/Principal | 01/02/2022 |
Training of Brent Warner
| Northwood University (Michigan) | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
- Stock Market
- Insiders
- Brent Warner
